Frank Vermeer

3.8k citations

50 papers · 2.5k indexed · 1 hit paper · h-index 19

Cardiology and Cardiovascular Medicine top 1%
Radiology, Nuclear Medicine and Imaging top 1%
Surgery top 5%
Internal Medicine top 2%
Emergency Medicine top 5%

Co-authors: Frits W. Bär Maarten L. Simoons X. H. Krauss Freek W.A. Verheugt Patrick W. Serruys Jacobus Lubsen Chris de Zwaan Willem J. Remme
Topics: Acute Myocardial Infarction Research (33 papers)Cardiac Imaging and Diagnostics (19 papers)Atrial Fibrillation Management and Outcomes (11 papers)
Cited by: Cardiology and Cardiovascular Medicine Internal Medicine Radiology, Nuclear Medicine and Imaging
Journals: The Lancet Circulation Journal of the American College of Cardiology
Partner nations: Netherlands Germany France

In The Last Decade

Frank Vermeer

50 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival

1986 405 citations Maarten L. Simoons, Patrick W. Serruys et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Frank Vermeer

Since Specialization

Citations

This map shows the geographic impact of Frank Vermeer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Vermeer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Vermeer more than expected).

Fields of papers citing papers by Frank Vermeer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Vermeer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Vermeer. The network helps show where Frank Vermeer may publish in the future.

Co-authorship network of co-authors of Frank Vermeer

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Vermeer. A scholar is included among the top collaborators of Frank Vermeer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Vermeer. Frank Vermeer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thrombolytic Therapy in Patients of Female Gender 2001 ·Thrombosis Research ·Frank Vermeer	4
2	Saruplase Is a Safe and Effective Thrombolytic Agent; Observations in 1698 Patients: Results of the PASS Study 1999 ·Journal of Thrombosis and Thrombolysis ·Frank Vermeer,(unknown),J. Meyer,Frits W. Bär,B Charbonnier,Jürgen Windeler,H. Barth	10
3	Early referral for intentional rescue PTCA after initiation of thrombolytic therapy in patients admitted to a community hospital because of a large acute myocardial infarction 1999 ·American Heart Journal ·(unknown),(unknown),Frank Vermeer,(unknown),(unknown),Hans de Swart,Vincent van Ommen,Chris de Zwaan,Domien J Engelen,W.R.M. Dassen,H. J. J. Wellens	26
4	Thrombolysis with saruplase versus streptokinase in acute myocardial infarction: Five-year results of the PRIMI Trial 1999 ·American Heart Journal ·Martin Spiecker,Jürgen Windeler,Frank Vermeer,Rolf Michels,Ricardo Seabra‐Gomes,Jürgen vom Dahl,Sebastian Kerber,Freek W.A. Verheugt,P. W. Westerhof,Frits W. Bär,Uwe Nixdorff,H. Barth,(unknown),(unknown),Jürgen Meyer	10
5	Primary Prevention of Arterial Thromboembolism in Nonrheumatic Atrial Fibrillation 1999 ·Controlled Clinical Trials ·(unknown),Machteld Langenberg,J. Lodder,Frank Vermeer,Hubert J. A. Schouten,(unknown),J W van Ree,J. André Knottnerus	9
6	Primary prevention of arterial thrombo-embolism in non-rheumatical atrial fibrillation. Results of the PATAF study 1998 ·Journal of the American College of Cardiology ·Frank Vermeer,Machteld Langenberg,(unknown),J. Lodder,Hubert J. A. Schouten,J W van Ree,J. André Knottnerus	7
7	Development of ST-Seament elevation and Q- and R-Wave changes in acute myocardial infarction and the influence of thrombolytic therapy 1996 ·The American Journal of Cardiology ·Frits W. Bär,Paul G.A. Volders,(unknown),Frank Vermeer,Jürgen Meyer,Hein J.J. Wellens	12
8	Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice: Fig 1 1996 ·BMJ ·Machteld Langenberg,(unknown),J W van Ree,Frank Vermeer,J. Lodder,Hubert J. A. Schouten,J. André Knottnerus	58
9	Changes in Wall Motion in Patients Treated for Unstable Angina 1995 ·CHEST Journal ·Chris de Zwaan,Frits W. Bär,W.R.M. Dassen,Frank Vermeer,Hein J.J. Wellens	2
10	Coronary angiographic findings do not predict clinical outcome in patients with unstable angina 1994 ·Journal of the American College of Cardiology ·Frits W. Bär,(unknown),Jean Renkin,Frank Vermeer,Chris de Zwaan,H. J. J. Wellens	7
11	The effect of taprostene in patients with acute myocardial infarction treated with thrombolytic therapy: results of the STARTstudy 1993 ·European Heart Journal ·Frits W. Bär,J. Meyer,Rolf Michels,R. Uebis,Stefan Lange,H. Barth,Robert M. Groves,Frank Vermeer	6
12	Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis 1991 ·Journal of the American College of Cardiology ·(unknown),Anton P.M. Gorgels,(unknown),Frank Vermeer,W.R.M. Dassen,Hein J.J. Wellens	102
13	Thrombolytic tyerapy has no clinical beneficial effect in patients with unstable angina a placebo controlied study in 159 patients 1991 ·Journal of the American College of Cardiology ·Frits W. Bär,Frank Vermeer,F.W.A. Verheugt,J. Col,(unknown),(unknown),(unknown),Jochen Metzger,(unknown),P Raynaud,C. de Zwaan	3
14	Saruplase, a new fibrin specific thrombolytic agent; efficacy and safety in the first 1000 patients 1991 ·Journal of the American College of Cardiology ·Frank Vermeer,(unknown),Jörg Meyer,(unknown),Rolf Michels,(unknown),(unknown),H. Barth,Leopold Flohé	4
15	Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands 1989 ·Journal of the American College of Cardiology ·Maarten L. Simoons,Jeroen Vos,Jan G.P. Tijssen,Frank Vermeer,Freek W.A. Verheugt,X. H. Krauss,V. Manger Cats	170
16	Immediate PTCA after successful thrombolysis with intracoronary streptokinase, three years follow-up 1988 ·European Heart Journal ·Frank Vermeer,Maarten L. Simoons,(unknown),Frits W. Bär,H. Suryapranata,P. Fioretti,Patrick W. Serruys,B. Buis,(unknown),Simon H. Braat,J Lubsen,Philip Hugenholtz	5
17	Rapid enzyme release from acutely infarcted myocardium after early thrombolyic therapy: Washout or reperfusion damage? 1988 ·American Heart Journal ·Arnoud van der Laarse,Ernst E. van der Wall,(unknown),Frank Vermeer,Freek W.A. Verheugt,X. H. Krauss,Frits W. Bär,Wim Th. Hermens,George M. Willems,Maarten L. Simoons	17
18	Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction 1987 ·The American Journal of Cardiology ·Frits W. Bär,Frank Vermeer,Chris de Zwaan,(unknown),(unknown),Maarten L. Simoons,Wim Th. Hermens,Arnoud van der Laarse,Freek W.A. Verheugt,X. H. Krauss,Hein J.J. Wellens	90
19	Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction 1986 ·Journal of the American College of Cardiology ·Patrick W. Serruys,Maarten L. Simoons,H. Suryapranata,Frank Vermeer,William Wijns,Marcel van den Brand,Frits W. Bär,Chris de Zwaan,X. H. Krauss,W. Remme,Jan Res,Freek W.A. Verheugt,R. van Domburg,Jacobus Lubsen,Paul G. Hugenholtz	255
20	Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survivalbreakdown → 1986 ·Journal of the American College of Cardiology ·Maarten L. Simoons,Patrick W. Serruys,Marcel van den Brand,Jan Res,Freek W.A. Verheugt,X. H. Krauss,Willem J. Remme,Frits W. Bär,Chris de Zwaan,Arnoud van der Laarse,Frank Vermeer,Jacobus Lubsen	405

About Frank Vermeer

Frank Vermeer is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Radiology, Nuclear Medicine and Imaging, having authored 50 papers that have together received 2.5k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (33 papers), Cardiac Imaging and Diagnostics (19 papers) and Atrial Fibrillation Management and Outcomes (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.1k citations), Internal Medicine (288 citations) and Radiology, Nuclear Medicine and Imaging (1.0k citations). Frank Vermeer has collaborated with scholars based in Netherlands, Germany and France. Frequent co-authors include Frits W. Bär, Maarten L. Simoons, X. H. Krauss, Freek W.A. Verheugt, Patrick W. Serruys, Jacobus Lubsen, Chris de Zwaan, Willem J. Remme, Arnoud van der Laarse and C. de Zwaan. Their work appears in journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact